Connect with us

Hi, what are you looking for?

Jewish Business News

IPOs

Israeli Mediwound Begins Trading On Nasdaq


The burns and wounds treatment developer is issuing 5 million shares at $14 each.

MEDIWOUND-2vkdbjsek7qbsoilz0yyo0

Burns and wounds treatment developer Mediwound will begin trading on the US Nasdaq market today. Clal Biotechnology Industries Ltd. (TASE: CBI), which holds a controlling 63% stake in Mediwound today notified the Tel Aviv Stock Exchange about the pricing of the IPO.

Credit Suisse Securities LLC, Jefferies, BMO Capital Markets and Oppenheimer & Co. are the underwriters. They will be offered the option to purchase 750, 000 additional regular shares at $14, which can be realized no later than 30 days from the IPO.

MediWound’s shares will begin trading Thursday under the MDWD ticker with the IPO to be completed no later than Tuesday March 25.

Published by Globes [online], Israel business news – www.globes-online.com 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Advertisement